CoChat

Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Abstract Background and aims Intestinal metaplasia (IM) of the stomach is associated with an increased risk of differentiated gastric cancer. While it is important to diagnose IM endoscopically, it can be difficult to observe by white-light endoscopy. In magnifying endoscopy with narrow-band imaging (M-NBI) of the stomach, a light-blue crest (LBC) is widely known to be a useful marker in the endoscopic diagnosis of IM. However, IM that exhibits only white opaque substance (WOS) without an LBC can also occur. The aim of this study was to elucidate whether the presence of WOS on M-NBI of the stomach could serve as a marker of IM in the same way that an LBC does. Methods The subjects were 40 consecutive patients who underwent M-NBI between July and December 2014. The primary endpoint in this study was to evaluate the diagnostic performance of M-NBI for histologically observed IM in WOS- and LBC-positive mucosa. Results The sensitivity and specificity of WOS for histologically diagnosed IM were 50.0 % (95 % confidence interval [CI] 40.0 % – 50.0 %) and 100.0 % (95 %CI 85.0 % – 100.0 %), respectively. Meanwhile, the sensitivity and specificity of LBC were 62.5 % (95 %CI 51.1 % – 65.9 %) and 93.8 % (95 %CI 76.7 % – 98.9 %), respectively. The sensitivity and specificity of WOS and/or LBC (WOS positive and LBC positive, WOS positive and LBC negative, or WOS negative and LBC positive) for histologically diagnosed IM were 87.5 % (95 %CI 76.9 % – 90.9 %) and 93.8 % (95 %CI 77.9 % – 98.9 %), respectively. Conclusions LBC and WOS are both useful markers for endoscopic diagnosis of IM. Combining both markers improves the sensitivity. Clinical trial number: UMINCTR000014453.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-0043-103409

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 68

Metadata

Authors
Kanemitsu, T., Yao, K., Nagahama, T., Imamura, K., Fujiwara, S., Ueki, T., Chuman, K., Tanabe, H., Atsuko, O., Iwashita, A., Shimokawa, T., Uchita, K., & Kanesaka, T.
Affiliations
  • Fukuoka University (JP)
  • Department of Pathology, Fukuoka University Chikushi Hospital, Fukuoka, Japan
  • Wakayama Medical University (JP)
  • Japanese Red Cross Kochi Hospital (JP)
  • Osaka International Cancer Institute (JP)
Venue
Endoscopy
Published
2017-04-10
Volume
49
Issue
06
Pages
529-535
ISSN
  • 0013-726X (ISSN-L)
  • 1438-8812
OpenAlex
W2606521355
Cited by
64
References
18
Citations by year
2026: 6 · 2025: 4 · 2024: 8 · 2023: 3 · 2022: 7 · 2021: 8 · 2020: 13 · 2019: 7 · 2018: 7 · 2017: 1
FWCI
6.36
Type
journal article
Language
en
Open access
closed
Locations
  • Endoscopy (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (15K00044)
Topics
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Keywords
intestinal metaplasia, gastric mucosa, magnifying narrow-band imaging, endoscopic diagnosis, diagnostic biomarkers, sensitivity and specificity, gastric cancer risk
MeSH terms
Aged, Biopsy, Cross-Sectional Studies, Female, Gastric Mucosa, Gastritis, Atrophic, Gastroscopy, Humans, Male, Metaplasia, Middle Aged, Biomarkers, Observer Variation, Helicobacter pylori, Helicobacter Infections, Disease Progression, Narrow Band Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.